252 related articles for article (PubMed ID: 36476563)
21. Role of Mast Cell-Derived Adenosine in Cancer.
Gorzalczany Y; Sagi-Eisenberg R
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137883
[TBL] [Abstract][Full Text] [Related]
22. Immunotherapy discovery on tumor organoid-on-a-chip platforms that recapitulate the tumor microenvironment.
Zhang J; Tavakoli H; Ma L; Li X; Han L; Li X
Adv Drug Deliv Rev; 2022 Aug; 187():114365. PubMed ID: 35667465
[TBL] [Abstract][Full Text] [Related]
23. Tryptase-positive mast cells correlate with angiogenesis in canine mammary carcinoma.
Im KS; Kim JH; Yhee JY; Yu CH; Kim NH; Nho WG; Sur JH
J Comp Pathol; 2011; 144(2-3):157-63. PubMed ID: 20934709
[TBL] [Abstract][Full Text] [Related]
24. Chemopreventive agents targeting tumor microenvironment.
Sharma SH; Thulasingam S; Nagarajan S
Life Sci; 2016 Jan; 145():74-84. PubMed ID: 26679106
[TBL] [Abstract][Full Text] [Related]
25. Havoc in harmony: Unravelling the intricacies of angiogenesis orchestrated by the tumor microenvironment.
Acharya SS; Kundu CN
Cancer Treat Rev; 2024 Jun; 127():102749. PubMed ID: 38714074
[TBL] [Abstract][Full Text] [Related]
26. Frenemies in the Microenvironment: Harnessing Mast Cells for Cancer Immunotherapy.
Sulsenti R; Jachetti E
Pharmaceutics; 2023 Jun; 15(6):. PubMed ID: 37376140
[TBL] [Abstract][Full Text] [Related]
27. Mast cells in breast cancer angiogenesis.
Cimpean AM; Tamma R; Ruggieri S; Nico B; Toma A; Ribatti D
Crit Rev Oncol Hematol; 2017 Jul; 115():23-26. PubMed ID: 28602166
[TBL] [Abstract][Full Text] [Related]
28. Mast Cell-Tumor Interactions: Molecular Mechanisms of Recruitment, Intratumoral Communication and Potential Therapeutic Targets for Tumor Growth.
Segura-Villalobos D; Ramírez-Moreno IG; Martínez-Aguilar M; Ibarra-Sánchez A; Muñoz-Bello JO; Anaya-Rubio I; Padilla A; Macías-Silva M; Lizano M; González-Espinosa C
Cells; 2022 Jan; 11(3):. PubMed ID: 35159157
[TBL] [Abstract][Full Text] [Related]
29. Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity.
Lee WS; Yang H; Chon HJ; Kim C
Exp Mol Med; 2020 Sep; 52(9):1475-1485. PubMed ID: 32913278
[TBL] [Abstract][Full Text] [Related]
30. The Janus Face of Tumor Microenvironment Targeted by Immunotherapy.
Buoncervello M; Gabriele L; Toschi E
Int J Mol Sci; 2019 Sep; 20(17):. PubMed ID: 31484464
[TBL] [Abstract][Full Text] [Related]
31. Mast cell marker gene signature in head and neck squamous cell carcinoma.
Cai Z; Tang B; Chen L; Lei W
BMC Cancer; 2022 May; 22(1):577. PubMed ID: 35610596
[TBL] [Abstract][Full Text] [Related]
32. Non-random spatial relationships between mast cells and microvessels in human endometrial carcinoma.
Guidolin D; Marinaccio C; Tortorella C; Annese T; Ruggieri S; Finato N; Crivellato E; Ribatti D
Clin Exp Med; 2017 Feb; 17(1):71-77. PubMed ID: 26886279
[TBL] [Abstract][Full Text] [Related]
33. Clinical relevance of tumor microenvironment: immune cells, vessels, and mouse models.
Katsuta E; Rashid OM; Takabe K
Hum Cell; 2020 Oct; 33(4):930-937. PubMed ID: 32507979
[TBL] [Abstract][Full Text] [Related]
34. The Roles of CD38 and CD157 in the Solid Tumor Microenvironment and Cancer Immunotherapy.
Wo YJ; Gan ASP; Lim X; Tay ISY; Lim S; Lim JCT; Yeong JPS
Cells; 2019 Dec; 9(1):. PubMed ID: 31861847
[TBL] [Abstract][Full Text] [Related]
35. Reprogramming the immunosuppressive tumor microenvironment: exploiting angiogenesis and thrombosis to enhance immunotherapy.
Shafqat A; Omer MH; Ahmed EN; Mushtaq A; Ijaz E; Ahmed Z; Alkattan K; Yaqinuddin A
Front Immunol; 2023; 14():1200941. PubMed ID: 37520562
[TBL] [Abstract][Full Text] [Related]
36. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
[TBL] [Abstract][Full Text] [Related]
37. Anti-angiogenesis: Opening a new window for immunotherapy.
Guo F; Cui J
Life Sci; 2020 Oct; 258():118163. PubMed ID: 32738363
[TBL] [Abstract][Full Text] [Related]
38. Mast cell contribution to angiogenesis related to tumour progression.
Ribatti D; Crivellato E; Roccaro AM; Ria R; Vacca A
Clin Exp Allergy; 2004 Nov; 34(11):1660-4. PubMed ID: 15544587
[TBL] [Abstract][Full Text] [Related]
39. The Microenvironment of Lung Cancer and Therapeutic Implications.
Mittal V; El Rayes T; Narula N; McGraw TE; Altorki NK; Barcellos-Hoff MH
Adv Exp Med Biol; 2016; 890():75-110. PubMed ID: 26703800
[TBL] [Abstract][Full Text] [Related]
40. Controversial role of mast cells in breast cancer tumor progression and angiogenesis.
Ribatti D; Annese T; Tamma R
Clin Breast Cancer; 2021 Dec; 21(6):486-491. PubMed ID: 34580034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
